Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares RepurchasedShort-Term Debt repayments
Ratios

SRx Health Solutions (SRXH) Long-Term Debt Issuances (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Long-Term Debt Issuances for 16 consecutive years, with $2.5 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Long-Term Debt Issuances fell 42.4% year-over-year to $2.5 million, compared with a TTM value of $12.5 million through Jun 2025, up 147.4%, and an annual FY2023 reading of $1.9 million, down 84.53% over the prior year.
  • Long-Term Debt Issuances was $2.5 million for Q2 2025 at SRx Health Solutions, up from $2.2 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $6.0 million in Q1 2021 and bottomed at -$4.9 million in Q4 2023.
  • Average Long-Term Debt Issuances over 5 years is $2.4 million, with a median of $2.5 million recorded in 2022.
  • The sharpest move saw Long-Term Debt Issuances surged 935.91% in 2022, then tumbled 200.85% in 2023.
  • Year by year, Long-Term Debt Issuances stood at $465000.0 in 2021, then soared by 935.91% to $4.8 million in 2022, then crashed by 200.85% to -$4.9 million in 2023, then skyrocketed by 172.33% to $3.5 million in 2024, then decreased by 29.71% to $2.5 million in 2025.
  • Business Quant data shows Long-Term Debt Issuances for SRXH at $2.5 million in Q2 2025, $2.2 million in Q1 2025, and $3.5 million in Q3 2024.